Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal

Authors: Masumi Ueda MD, MA1,2,3, Renato Martins MD, MPH1,2,3, Paul C. Hendrie MD, PhD1,2,4, Terry McDonnell DNP, ACNP-BC1, Jennie R. Crews MD, MMM1,3, Tracy L. Wong MBA1, Brittany McCreery MD, MBA1, Barbara Jagels RN, MHA1, Aaron Crane MHA1, David R. Byrd MD1,5, Steven A. Pergam MD, MPH1,6,7, Nancy E. Davidson MD1,2,3, Catherine Liu MD1,6,7, and F. Marc Stewart MD1,2,3
View More View Less
  • 1 Seattle Cancer Care Alliance;
  • | 2 Clinical Research Division, Fred Hutchinson Cancer Research Center;
  • | 3 Division of Medical Oncology, Department of Medicine, University of Washington;
  • | 4 Division of Hematology, Department of Medicine, University of Washington;
  • | 5 Department of Surgery, University of Washington;
  • | 6 Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center; and
  • | 7 Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington
Restricted access

The first confirmed case of coronavirus disease 2019 (COVID-19) in the United States was reported on January 20, 2020, in Snohomish County, Washington. At the epicenter of COVID-19 in the United States, the Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center, and University of Washington are at the forefront of delivering care to patients with cancer during this public health crisis. This Special Feature highlights the unique circumstances and challenges of cancer treatment amidst this global pandemic, and the importance of organizational structure, preparation, agility, and a shared vision for continuing to provide cancer treatment to patients in the face of uncertainty and rapid change.

Submitted March 15, 2020; accepted for publication March 16, 2020.

Disclosures: The authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.

Correspondence: Masumi Ueda, MD, MA, Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, D1-100, Seattle, WA 98109. Email: mueda@fredhutch.org
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 22562 11410 994
PDF Downloads 6242 2239 290
EPUB Downloads 0 0 0